Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 2900

1.

Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase.

Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J.

Sci Rep. 2020 Feb 21;10(1):3531. doi: 10.1038/s41598-020-58955-y.

2.

Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.

Mishra H, Reeve BWP, Palmer Z, Caldwell J, Dolby T, Naidoo CC, Jackson JG, Schumacher SG, Denkinger CM, Diacon AH, van Helden PD, Marx FM, Warren RM, Theron G.

Lancet Respir Med. 2020 Feb 14. pii: S2213-2600(19)30370-4. doi: 10.1016/S2213-2600(19)30370-4. [Epub ahead of print]

PMID:
32066534
3.

Phylogenomic assessment of drug-resistant Mycobacterium tuberculosis strains from Beira, Mozambique.

Namburete EI, Dippenaar A, Conceição EC, Feliciano C, Nascimento MMPD, Peronni KC, Silva WA Jr, Ferro JJ, Harrison LH, Warren RM, Bollela VR.

Tuberculosis (Edinb). 2020 Jan 29;121:101905. doi: 10.1016/j.tube.2020.101905. [Epub ahead of print]

PMID:
32063558
4.

Extract from used Xpert MTB/RIF Ultra cartridges is useful for accurate second-line drug-resistant tuberculosis diagnosis with minimal rpoB-amplicon cross-contamination risk.

Venter R, Minnies S, Derendinger B, Tshivhula H, de Vos M, Dolby T, Ruiters A, Warren RM, Theron G.

Sci Rep. 2020 Feb 14;10(1):2633. doi: 10.1038/s41598-020-59164-3.

5.

Ixekizumab for the treatment of psoriasis: up-to-date.

Craig S, Warren RB.

Expert Opin Biol Ther. 2020 Feb 12. doi: 10.1080/14712598.2020.1729736. [Epub ahead of print]

PMID:
32050819
6.

Response to "Letter Regarding: Radiographic Analysis of National Football League Players' Fifth Metatarsal Morphology Relationship to Proximal Fifth Metatarsal Fracture Risk".

Karnovsky SC, Rosenbaum AJ, DeSandis B, Johnson C, Murphy CI, Warren RF, Taylor SA, Drakos MC.

Foot Ankle Int. 2020 Feb;41(2):248. doi: 10.1177/1071100719898276. No abstract available.

PMID:
32045285
7.

A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.

Cro S, Patel P, Barker J, Burden DA, Griffiths CEM, Lachmann HJ, Reynolds NJ, Warren RB, Capon F, Smith C, Cornelius V.

Trials. 2020 Feb 10;21(1):158. doi: 10.1186/s13063-020-4103-z.

8.

Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.

Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Gottlieb AB, Assudani D, Bedford-Rice K, Coarse J, Ink B, McInnes IB.

Lancet. 2020 Feb 8;395(10222):427-440. doi: 10.1016/S0140-6736(19)33161-7.

PMID:
32035552
9.

Rifampicin Resistant Tuberculosis in Lesotho: Diagnosis, Treatment Initiation and Outcomes.

Katende B, Esterhuizen TM, Dippenaar A, Warren RM.

Sci Rep. 2020 Feb 5;10(1):1917. doi: 10.1038/s41598-020-58690-4.

10.

The role of the IL-23/Th17 pathway in cardio-metabolic comorbidity associated with psoriasis.

Egeberg A, Gisondi P, Carrascosa JM, Warren RB, Mrowietz U.

J Eur Acad Dermatol Venereol. 2020 Feb 5. doi: 10.1111/jdv.16273. [Epub ahead of print] Review.

PMID:
32022950
11.

Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.

Van Rie A, Whitfield MG, De Vos E, Scott L, Da Silva P, Hayes C, Heupink TH, Sirgel FA, Stevens W, Warren RM.

J Antimicrob Chemother. 2020 Feb 4. pii: dkz564. doi: 10.1093/jac/dkz564. [Epub ahead of print]

PMID:
32016320
12.

A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic.

Klopper M, Heupink TH, Hill-Cawthorne G, Streicher EM, Dippenaar A, de Vos M, Abdallah AM, Limberis J, Merker M, Burns S, Niemann S, Dheda K, Posey J, Pain A, Warren RM.

BMC Med. 2020 Feb 4;18(1):24. doi: 10.1186/s12916-019-1487-2.

13.

Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review.

Al-Janabi A, Foulkes AC, Mason K, Smith CH, Griffiths C, Warren RB.

J Eur Acad Dermatol Venereol. 2020 Jan 30. doi: 10.1111/jdv.16246. [Epub ahead of print] Review.

PMID:
31997406
14.

Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study.

Pan S, Tsakok T, Dand N, Lonsdale DO, Loeff FC, Bloem K, de Vries A, Baudry D, Duckworth M, Mahil S, Pushpa-Rajah A, Russell A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, David Burden A, Rispens T, Standing JF, Smith CH; BADBIR Study Group, the BSTOP Study Group, the PSORT Consortium.

Clin Transl Sci. 2020 Jan 29. doi: 10.1111/cts.12725. [Epub ahead of print]

PMID:
31995663
15.

Postsynaptic integrative properties of dorsal CA1 pyramidal neuron subpopulations.

Masurkar AV, Tian C, Warren R, Reyes I, Lowes DC, Brann DH, Siegelbaum SA.

J Neurophysiol. 2020 Jan 22. doi: 10.1152/jn.00397.2019. [Epub ahead of print]

PMID:
31967926
16.

Establishment of an eHAP1 human haploid cell line hybrid reference genome assembled from short and long reads.

Law WD, Warren RL, McCallion AS.

Genomics. 2020 Jan 18. pii: S0888-7543(19)30906-1. doi: 10.1016/j.ygeno.2020.01.009. [Epub ahead of print]

PMID:
31962144
17.

Risankizumab vs. adalimumab for moderate-to-severe plaque psoriasis: a critical appraisal.

Al-Janabi A, Warren RB.

Br J Dermatol. 2020 Jan 3. doi: 10.1111/bjd.18856. [Epub ahead of print] No abstract available.

PMID:
31899817
18.

Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis.

Warren RB, Gooderham M, Burge R, Zhu B, Amato D, Liu KH, Shrom D, Guo J, Brnabic A, Blauvelt A.

J Am Acad Dermatol. 2019 Dec 26. pii: S0190-9622(19)33315-8. doi: 10.1016/j.jaad.2019.12.038. [Epub ahead of print]

19.

Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis.

Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK.

J Surg Oncol. 2019 Dec 11. doi: 10.1002/jso.25811. [Epub ahead of print]

PMID:
31828813
20.

Controlling energy levels and Fermi level en route to fully tailored energetics in organic semiconductors.

Warren R, Privitera A, Kaienburg P, Lauritzen AE, Thimm O, Nelson J, Riede MK.

Nat Commun. 2019 Dec 5;10(1):5538. doi: 10.1038/s41467-019-13563-x.

21.

Overcoming limitations of tuberculosis information systems: researcher and clinician perspectives.

van der Heijden YF, Hughes J, Dowdy DW, Streicher E, Chihota V, Jacobson KR, Warren R, Theron G.

Public Health Action. 2019 Sep 21;9(3):120-127. doi: 10.5588/pha.19.0014.

22.

Histological and Gene Expression Analysis of the Effects of Menopause Status and Hormone Therapy on the Vaginal Introitus and Labia Majora.

Binder RL, Freedman MA, Sharma KB, Farage MA, Wang Y, Combs C, Moore D, Tiesman JP, Bascom CC, Isfort RJ, Warren R.

J Clin Med Res. 2019 Nov;11(11):745-759. doi: 10.14740/jocmr4006. Epub 2019 Oct 29.

23.

Reverse zoonotic tuberculosis transmission from an emerging Uganda I strain between pastoralists and cattle in South-Eastern Nigeria.

Adesokan HK, Akinseye VO, Streicher EM, Van Helden P, Warren RM, Cadmus SI.

BMC Vet Res. 2019 Dec 4;15(1):437. doi: 10.1186/s12917-019-2185-1.

24.

Long-term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease.

Reich K, Warren RB, Coates LC, Di Comite G.

J Eur Acad Dermatol Venereol. 2019 Nov 30. doi: 10.1111/jdv.16124. [Epub ahead of print] Review.

PMID:
31785165
25.

Minority Mycobacterium tuberculosis Genotypic Populations as an Indicator of Subsequent Phenotypic Resistance.

Engelthaler DM, Streicher EM, Kelley EJ, Allender CJ, Wiggins K, Jimenez D, Lemmer D, Vittinghoff E, Theron G, Sirgel FA, Warren RM, Metcalfe JZ.

Am J Respir Cell Mol Biol. 2019 Dec;61(6):789-791. doi: 10.1165/rcmb.2019-0178LE. No abstract available.

PMID:
31774334
26.

Test Characteristics of Assays to Detect Mycobacterium bovis Infection in High-Prevalence African Buffalo (Syncerus caffer) Herds.

Bernitz N, Kerr TJ, de Waal C, Cooper DV, Warren RM, Van Helden PD, Parsons SDC, Miller MA.

J Wildl Dis. 2019 Nov 21. [Epub ahead of print]

PMID:
31750773
27.

The biomechanics of subscapularis repair in reverse shoulder arthroplasty: The effect of lateralization and insertion site.

Eno JT, Kontaxis A, Novoa-Boldo A, Windsor E, Chen X, Erickson BJ, Warren RF, Dines DM, Dines JS, Gulotta LV, Taylor SA.

J Orthop Res. 2019 Nov 19. doi: 10.1002/jor.24531. [Epub ahead of print]

PMID:
31743476
28.

Cytokine gene expression assay as a diagnostic tool for detection of Mycobacterium bovis infection in warthogs (Phacochoerus africanus).

Roos EO, Scott LA, Ndou S, Olea-Popelka F, Buss PE, de Klerk-Lorist LM, Warren RM, van Helden PD, Sylvester TT, Miller MA, Parsons SDC.

Sci Rep. 2019 Nov 11;9(1):16525. doi: 10.1038/s41598-019-53045-0.

29.

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses.

Warren RB, See K, Burge R, Zhang Y, Brnabic A, Gallo G, Garrelts A, Egeberg A.

Dermatol Ther (Heidelb). 2020 Feb;10(1):73-86. doi: 10.1007/s13555-019-00337-y. Epub 2019 Nov 4.

30.

Parallel Signaling through IRE1α and PERK Regulates Pancreatic Neuroendocrine Tumor Growth and Survival.

Moore PC, Qi JY, Thamsen M, Ghosh R, Peng J, Gliedt MJ, Meza-Acevedo R, Warren RE, Hiniker A, Kim GE, Maly DJ, Backes BJ, Papa FR, Oakes SA.

Cancer Res. 2019 Dec 15;79(24):6190-6203. doi: 10.1158/0008-5472.CAN-19-1116. Epub 2019 Oct 31.

PMID:
31672843
31.

Detection of Second Line Drug Resistance among Drug Resistant Mycobacterium Tuberculosis Isolates in Botswana.

Mogashoa T, Melamu P, Derendinger B, Ley SD, Streicher EM, Iketleng T, Mupfumi L, Mokomane M, Kgwaadira B, Rankgoane-Pono G, Tsholofelo TT, Kasvosve I, Moyo S, Warren RM, Gaseitsiwe S.

Pathogens. 2019 Oct 28;8(4). pii: E208. doi: 10.3390/pathogens8040208.

32.

Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis.

Langley RGB, Reich K, Strand V, Feldman SR, Paul C, Gordon K, Warren RB, Toth D, Nikaï E, Zhu B, Goldblum O, Edson-Heredia E, Carlier H, Burge R, Lin CY, Hollister K, Augustin M.

Qual Life Res. 2020 Feb;29(2):369-380. doi: 10.1007/s11136-019-02296-5. Epub 2019 Oct 26.

PMID:
31655974
33.

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study.

Rungapiromnan W, Mason KJ, Lunt M, McElhone K, Burden AD, Rutter MK, Warren RB, Griffiths CEM, Ashcroft DM; BADBIR Study Group.

J Eur Acad Dermatol Venereol. 2019 Oct 21. doi: 10.1111/jdv.16018. [Epub ahead of print]

PMID:
31633837
34.

Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE).

Warren RB, Barker JNWB, Finlay AY, Burden AD, Kirby B, Armendariz Y, Williams R, Hatchard C, Khare S, Griffiths CEM.

Br J Dermatol. 2019 Oct 18. doi: 10.1111/bjd.18623. [Epub ahead of print]

PMID:
31628677
35.

Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.

Bouton TC, de Vos M, Ragan EJ, White LF, Van Zyl L, Theron D, Horsburgh CR, Warren RM, Jacobson KR.

PLoS One. 2019 Oct 17;14(10):e0223308. doi: 10.1371/journal.pone.0223308. eCollection 2019.

36.

Predictors of patient satisfaction after reverse shoulder arthroplasty.

Rauck RC, Ruzbarsky JJ, Swarup I, Gruskay J, Dines JS, Warren RF, Dines DM, Gulotta LV.

J Shoulder Elbow Surg. 2020 Mar;29(3):e67-e74. doi: 10.1016/j.jse.2019.07.043. Epub 2019 Oct 13.

PMID:
31619353
37.

Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumors.

Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK.

J Surg Oncol. 2019 Dec;120(8):1311-1317. doi: 10.1002/jso.25727. Epub 2019 Oct 15.

PMID:
31613999
38.

The human imperative of stabilizing global climate change at 1.5°C.

Hoegh-Guldberg O, Jacob D, Taylor M, Guillén Bolaños T, Bindi M, Brown S, Camilloni IA, Diedhiou A, Djalante R, Ebi K, Engelbrecht F, Guiot J, Hijioka Y, Mehrotra S, Hope CW, Payne AJ, Pörtner HO, Seneviratne SI, Thomas A, Warren R, Zhou G.

Science. 2019 Sep 20;365(6459). pii: eaaw6974. doi: 10.1126/science.aaw6974. Review.

PMID:
31604209
39.

Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.

Georghiou SB, Schumacher SG, Rodwell TC, Colman RE, Miotto P, Gilpin C, Ismail N, Rodrigues C, Warren R, Weyer K, Zignol M, Arafah S, Cirillo DM, Denkinger CM.

J Infect Dis. 2019 Oct 8;220(Supplement_3):S126-S135. doi: 10.1093/infdis/jiz106.

PMID:
31593599
40.

Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis.

Tsakok T, Wilson N, Dand N, Loeff FC, Bloem K, Baudry D, Duckworth M, Pan S, Pushpa-Rajah A, Standing JF, de Vries A, Alsharqi A, Becher G, Murphy R, Wahie S, Wright A, Griffiths CEM, Reynolds NJ, Barker J, Warren RB, Burden AD, Rispens T, Stocken D, Smith C; British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR) Study Group and the Psoriasis Stratification to Optimise Relevant Therapy (PSORT) Consortium.

JAMA Dermatol. 2019 Sep 18. doi: 10.1001/jamadermatol.2019.1783. [Epub ahead of print]

41.

An interferon-gamma release assay for the diagnosis of the Mycobacterium bovis infection in white rhinoceros (Ceratotherium simum).

Chileshe J, Roos EO, Goosen WJ, Buss P, Hausler G, Rossouw L, Manemela T, van Helden P, Warren R, Parsons SD, Miller M.

Vet Immunol Immunopathol. 2019 Nov;217:109931. doi: 10.1016/j.vetimm.2019.109931. Epub 2019 Aug 15.

PMID:
31522092
42.

Hippocampal-Prefrontal Theta Transmission Regulates Avoidance Behavior.

Padilla-Coreano N, Canetta S, Mikofsky RM, Alway E, Passecker J, Myroshnychenko MV, Garcia-Garcia AL, Warren R, Teboul E, Blackman DR, Morton MP, Hupalo S, Tye KM, Kellendonk C, Kupferschmidt DA, Gordon JA.

Neuron. 2019 Nov 6;104(3):601-610.e4. doi: 10.1016/j.neuron.2019.08.006. Epub 2019 Sep 11.

PMID:
31521441
43.

Ataxia-telangiectasia mutated is required for the development of protective immune memory after influenza A virus infection.

Warren R, Domm W, Yee M, Campbell A, Malone J, Wright T, Mayer-Pröschel M, O'Reilly MA.

Am J Physiol Lung Cell Mol Physiol. 2019 Nov 1;317(5):L591-L601. doi: 10.1152/ajplung.00031.2019. Epub 2019 Sep 11.

PMID:
31509427
44.

Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.

Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, Moreno V, Warren RS, Lothe RA, Guinney J.

Ann Oncol. 2019 Oct 1;30(10):1622-1629. doi: 10.1093/annonc/mdz287.

45.

Increased sensitivity to traumatic axonal injury on postconcussion diffusion tensor imaging scans in National Football League players by using premorbid baseline scans.

Niogi SN, Luther N, Kutner K, Shetty T, McCrea HJ, Barnes R, Weiss L, Warren RF, Rodeo SA, Zimmerman RD, Tsiouris AJ, Härtl R.

J Neurosurg. 2019 Sep 6:1-9. doi: 10.3171/2019.3.JNS181864. [Epub ahead of print]

PMID:
31491763
46.

The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis.

Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group.

Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2. Review.

PMID:
31486393
47.

Impact of Mycobacterium bovis-induced pathology on interpretation of QuantiFERON®-TB Gold assay results in African buffaloes (Syncerus caffer).

Bernitz N, Kerr TJ, Goosen WJ, Higgitt RL, de Waal C, Clarke C, Cooper DV, Warren RM, van Helden PD, Parsons SDC, Miller MA.

Vet Immunol Immunopathol. 2019 Nov;217:109923. doi: 10.1016/j.vetimm.2019.109923. Epub 2019 Aug 8.

PMID:
31470250
48.

Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.

Sandlund J, Estis J, Katzenbach P, Nolan N, Hinson K, Herres J, Pero T, Peterson G, Schumaker JM, Stevig C, Warren R, West T, Chow SK.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e00945-19. doi: 10.1128/JCM.00945-19. Print 2019 Nov.

PMID:
31434726
49.

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.

Ronacher K, Chegou NN, Kleynhans L, Djoba Siawaya JF, du Plessis N, Loxton AG, Maasdorp E, Tromp G, Kidd M, Stanley K, Kriel M, Menezes A, Gutschmidt A, van der Spuy GD, Warren RM, Dietze R, Okwera A, Thiel B, Belisle JT, Cliff JM, Boom WH, Johnson JL, van Helden PD, Dockrell HM, Walzl G.

Tuberculosis (Edinb). 2019 Sep;118:101859. doi: 10.1016/j.tube.2019.101859. Epub 2019 Aug 12.

50.

The fragility of findings of randomized controlled trials in shoulder and elbow surgery.

Ruzbarsky JJ, Rauck RC, Manzi J, Khormaee S, Jivanelli B, Warren RF.

J Shoulder Elbow Surg. 2019 Dec;28(12):2409-2417. doi: 10.1016/j.jse.2019.04.051. Epub 2019 Aug 14.

PMID:
31420227

Supplemental Content

Loading ...
Support Center